The University of New Mexico School of Medicine seeks individuals to participate in a clinical research study to evaluate an investigational medication that may potentially reduce joint deterioration caused by rheumatoid arthritis.

Approximately 2.1 million Americans are affected by rheumatoid arthritis which causes inflammation in the lining of the joint and/or other internal organs. It tends to persist for may years. Anyone can get rheumatoid arthritis including children and elderly. However, it usually begins in the early-to-middle adult years.

To qualify for the study, participants must have been diagnosed with rheumatoid arthritis for at least six months. Participants must be 18 or older and currently taking methotrexate. Qualified participants will receive study-related physical exams by a rheumatologist, study-related laboratory tests, x-rays and study medication.

For more information, call Rita at 272-2836.
Contact: HSC Public Affairs, 272-3322